Table of Contents 1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview 1.1 Product Overview and Scope of PARP (Poly ADP-Ribose Polymerase) Inhibitor 1.2 Classification of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Types 1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Comparison by Types (2017-2023) 1.2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Types in 2017 1.2.3 Started Phase I 1.2.4 Started Phase II 1.2.5 Started Phase III 1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Application 1.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospitals 1.3.3 Drug Stores 1.3.4 Online 1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Regions 1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2013-2023) 1.5 Global Market Size of PARP (Poly ADP-Ribose Polymerase) Inhibitor (2013-2023) 2 Manufacturers Profiles 2.1 Tesaro 2.1.1 Business Overview 2.1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) 2.2 Clovis Oncology 2.2.1 Business Overview 2.2.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) 2.3 AstraZeneca 2.3.1 Business Overview 2.3.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) 2.4 Abbvie 2.4.1 Business Overview 2.4.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Abbvie PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) 3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competition, by Players 3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Players Market Share 3.2.2 Top 10 PARP (Poly ADP-Ribose Polymerase) Inhibitor Players Market Share 3.3 Market Competition Trend 4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions 4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Regions 4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 4.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 4.5 South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 5 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries 5.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) 5.2 USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 5.3 Canada PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 5.4 Mexico PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 6 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries 6.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) 6.2 Germany PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 6.3 UK PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 6.4 France PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 6.5 Russia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 6.6 Italy PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 7 Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries 7.1 Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) 7.2 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 7.3 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 7.4 Korea PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 7.5 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 8 South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries 8.1 South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) 8.2 Brazil PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 8.3 Argentina PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 8.4 Colombia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue PARP (Poly ADP-Ribose Polymerase) Inhibitor by Countries 9.1 Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) 9.2 Saudi Arabia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 9.3 UAE PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 9.4 Egypt PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 9.5 Nigeria PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 9.6 South Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) 10 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment by Type 10.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Type (2013-2018) 10.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Forecast by Type (2018-2023) 10.3 Started Phase I Revenue Growth Rate (2013-2023) 10.4 Started Phase II Revenue Growth Rate (2013-2023) 10.5 Started Phase III Revenue Growth Rate (2013-2023) 11 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment by Application 11.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Application (2013-2018) 11.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Forecast by Application (2018-2023) 11.3 Hospitals Revenue Growth (2013-2018) 11.4 Drug Stores Revenue Growth (2013-2018) 11.5 Online Revenue Growth (2013-2018) 12 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2018-2023) 12.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2018-2023) 12.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Forecast by Regions (2018-2023) 12.3 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) 12.4 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) 12.6 South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure PARP (Poly ADP-Ribose Polymerase) Inhibitor Picture Table Product Specifications of PARP (Poly ADP-Ribose Polymerase) Inhibitor Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor and Revenue (Million USD) Market Split by Product Type Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Types in 2017 Figure Started Phase I Picture Figure Started Phase II Picture Figure Started Phase III Picture Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Application (2013-2023) Figure PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Applications in 2017 Figure Hospitals Picture Figure Drug Stores Picture Figure Online Picture Table Global Market PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (2013-2023) Figure South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (2013-2023) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (2013-2023) Table Tesaro Basic Information, Manufacturing Base and Competitors Table Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications Table Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) Table Clovis Oncology Basic Information, Manufacturing Base and Competitors Table Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications Table Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications Table AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) Table Abbvie Basic Information, Manufacturing Base and Competitors Table Abbvie PARP (Poly ADP-Ribose Polymerase) Inhibitor Type and Applications Table Abbvie PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue, Gross Margin and Market Share (2016-2017) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Players (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Players (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Players in 2016 Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Players in 2017 Figure Global Top 5 Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share in 2017 Figure Global Top 10 Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share in 2017 Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Regions (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Regions (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Regions (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Regions in 2017 Figure North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Table North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) Table North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries in 2017 Figure USA PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Canada PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Mexico PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Table Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Countries (2013-2018) Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries in 2017 Figure Germany PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure UK PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure France PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Russia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Italy PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Table Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries in 2017 Figure China PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Korea PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure India PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Table South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Countries (2013-2018) Table South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries in 2017 Figure Brazil PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Argentina PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Colombia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Table Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Countries in 2017 Figure Saudi Arabia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure UAE PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Egypt PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure Nigeria PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Figure South Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) by Type (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Type (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Type (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Type in 2017 Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Forecast by Type (2018-2023) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share Forecast by Type (2018-2023) Figure Global Started Phase I Revenue Growth Rate (2013-2018) Figure Global Started Phase II Revenue Growth Rate (2013-2018) Figure Global Started Phase III Revenue Growth Rate (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2013-2018) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Application (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Application (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Application in 2017 Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Forecast by Application (2018-2023) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share Forecast by Application (2018-2023) Figure Global Hospitals Revenue Growth Rate (2013-2018) Figure Global Drug Stores Revenue Growth Rate (2013-2018) Figure Global Online Revenue Growth Rate (2013-2018) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share Forecast by Regions (2018-2023) Figure North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) Figure Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) Figure South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023) Figure Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Forecast (2018-2023)

Tesaro Clovis Oncology AstraZeneca Abbvie